These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 31850625)
21. A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Golub LM; Ramamurthy NS; Llavaneras A; Ryan ME; Lee HM; Liu Y; Bain S; Sorsa T Ann N Y Acad Sci; 1999 Jun; 878():290-310. PubMed ID: 10415737 [TBL] [Abstract][Full Text] [Related]
22. Chemically modified tetracyclines: The novel host modulating agents. Swamy DN; Sanivarapu S; Moogla S; Kapalavai V J Indian Soc Periodontol; 2015; 19(4):370-4. PubMed ID: 26392682 [TBL] [Abstract][Full Text] [Related]
23. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation. Gu Y; Lee HM; Sorsa T; Salminen A; Ryan ME; Slepian MJ; Golub LM Pharmacol Res; 2011 Dec; 64(6):573-9. PubMed ID: 21771657 [TBL] [Abstract][Full Text] [Related]
24. Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis. Agnihotri R; Gaur S Indian J Pharmacol; 2012 Mar; 44(2):161-7. PubMed ID: 22529468 [TBL] [Abstract][Full Text] [Related]
25. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Ryan ME; Greenwald RA; Golub LM Curr Opin Rheumatol; 1996 May; 8(3):238-47. PubMed ID: 8796985 [TBL] [Abstract][Full Text] [Related]
26. Modulation of the host response in the treatment of periodontitis. Golub LM; Ryan ME; Williams RC Dent Today; 1998 Oct; 17(10):102-6, 108-9. PubMed ID: 10752438 [TBL] [Abstract][Full Text] [Related]